Janux Therapeutics (JANX) Gets Initiated With a Buy Rating at Truist Financial
Janux Therapeutics, Inc. (NASDAQ:JANX) is one of the best small cap stocks with the highest upside. Janux Therapeutics, Inc.
Janux Therapeutics Inc. (JANX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 11,189,693 | $258,481,908 | 4.35% | |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 2,525,000 | $58,327,500 | -31% | 0.1% |
| 3. | Point72 Asset Management Steve Cohen | 2,143,900 | $49,524,090 | +470% | 0.1% |
| 4. | Cormorant Asset Management Bihua Chen | 1,500,000 | $34,650,000 | -25% | 2.58% |
| 5. | EcoR1 Capital Oleg Nodelman | 1,469,818 | $33,952,796 | 2.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.02 | 110,206 | $3,418,590.12 | 10,141,287 | 2025-03-07 | Filing | |
| $30.78 | 372,093 | $11,453,022.54 | 10,031,081 | 2025-03-06 | Filing | |
| $31.30 | 37,455 | $1,172,341.50 | 9,658,988 | 2025-03-05 | Filing | |
| $30.56 | 304,287 | $9,299,010.72 | 9,621,533 | 2025-03-05 | Filing | |
| $44.75 | 1,200,000 | $53,700,000.00 | 9,317,246 | 2024-10-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $32.60 | 400 | $13,041.36 | 82,139 | 2025-05-01 | Filing | |
| $31.95 | 2,933 | $93,703.19 | 82,539 | 2025-05-01 | Filing | |
| $30.00 | 3,334 | $100,020.00 | 82,139 | 2025-04-21 | Filing | |
| $32.85 | 901 | $29,598.66 | 82,139 | 2025-03-03 | Filing | |
| $31.88 | 2,433 | $77,575.72 | 83,040 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 55,773 | $1,363,092 | 0.01% | |
| 2. | 8,454 | $206,616 | 0% | |
| 3. | 8,400 | $205,296 | 0% | |
| 4. | 2,960 | $72,342 | 0% | |
| 5. | 1,810 | $44,236 | 0% |
News See All
11 Best Small Cap Stocks with the Highest Upside
She stated that small caps show possibility, as a lot of them are rate sensitive, a little bit more levered, and are helped by lower rates, which is why there has been a lot of momentum behind small caps...
Truist Initiates Coverage on Janux Therapeutics (JANX) with a Buy Rating, $100 PT
Janux Therapeutics Inc. (NASDAQ:JANX) is one of the best up and coming stocks with huge upside potential.
10 Best Up and Coming Stocks with Huge Upside Potential
On August 20, Andres Garcia-Amaya, Zoe Financial CEO, joined 'The Exchange' on CNBC to discuss how IPO pops will draw in private companies to become public.
Janux Therapeutics Receives $10M Milestone Payment from Merck for Advancing Cancer Therapy Collaboration
Janux Therapeutics Inc. (NASDAQ:JANX) is one of the best small cap stocks with biggest upside potential.
9 Best Small Cap Stocks with Biggest Upside Potential
On August 14, Jonathan Krinsky of BTIG, joined 'Closing Bell' on CNBC to discuss whether the recent rally in small cap stocks is sustainable.
JonesTrading Remains Bullish on Janux Therapeutics (JANX) With a $90 Price Target
Janux Therapeutics, Inc. (NASDAQ:JANX) is one of the 13 Small Cap Stocks Analysts Are Bullish On. On May 14, JonesTrading analyst Soumit Roy maintained a bullish stance on Janux Therapeutics, Inc.
13 Small Cap Stocks Analysts Are Bullish On
On June 23, Jason Thomas, Carlyle's head of global research and investment strategy, appeared on CNBC’s ‘Squawk Box’ to talk about the state of the market and economy in light of the recent financial...
Unknown Billionaire Phill Gross’ 10 Stock Picks with Huge Upside Potential
Phillip “Phill” Gross is a seasoned investor and influential figure in the world of institutional asset management, best known as the Co-founder, Managing Director, and Healthcare Portfolio Manager...
Top 11 Small Cap Stocks to Buy with Biggest Upside Potential
On April 24, Jill Carey Hall, BofA Securities head of U.S. small/mid-cap strategy, appeared on 'Closing Bell' to talk about the impact of tariffs on small caps.
Hedge Fund Resource Center Billionaire Hedge Funds
